Evidence map›Paper›PMID 27342199›Full record

ArticleBMC microbiology2016

Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe.

Stéphanie Guyomard-Rabenirina, Joyce Malespine, Célia Ducat, Syndia Sadikalay, Mélanie Falord, Dorothée Harrois, Vincent Richard, Charles Dozois, Laboratory working group, Sébastien Breurec and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Cranberry juice potentiates sensitivity of uropathogenicApplied and environmental microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Emergence of a Novel Lineage and Wide Spread of aAntibiotics (Basel, Switzerland) · 2022
    Article
  6. High Prevalence ofFrontiers in microbiology · 2022
    Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Stéphanie Guyomard-RabenirinaUnité Environnement Santé, Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe, France. sguyomard@pasteur-guadeloupe.fr.
Joyce MalespineUnité Environnement Santé, Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe, France.
Célia DucatUnité Environnement Santé, Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe, France.
Syndia SadikalayUnité Environnement Santé, Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe, France.
Mélanie FalordUnité Environnement Santé, Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe, France.
Dorothée HarroisLaboratoire de Biologie Clinique, Centre Hospitalier de Basse-Terre, Basse-Terre, Guadeloupe, France.
Vincent RichardInstitut Pasteur de Nouvelle-Calédonie, Nouméa, Nouvelle-Calédonie, France.
Charles DozoisInstitut Armand Frappier, Laval, Canada.
Laboratory working group
Sébastien BreurecUnité Environnement Santé, Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe, France.
Antoine TalarminUnité Environnement Santé, Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe, France.
Institut Pasteur de la Guadeloupe · GPCentre Hospitalier Universitaire Pointe-à-Pitre · GPInstitut National de la Recherche Scientifique · CAInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrinary tract infections are bacterial infections most commonly encountered in the community. The resistance rate of uropathogens to commonly prescribed antibiotics has increased worldwide but there are no published data concerning the resistance of strains isolated from community-acquired UTI in Guadeloupe. To assess the susceptibility patterns of Enterobacteriaceae strains isolated from outpatients in Guadeloupe we conducted a prospective study from December 2012 to May 2014 among outpatients consulting at private and public laboratories for urine analysis. Risk factors for E. coli resistance to amoxicillin, third-generation cephalosporin, and ciprofloxacin were also determined. To study the trends of E. coli resistance rates over the past 10 years, data on the susceptibility patterns of E. coli from 2003 to 2014 were also collected from three major laboratories for a retrospective study.

resultsDuring the prospective study, we isolated 1293 bacterial strains from the urine of outpatients presenting for urine analysis. The most commonly isolated bacteria were E. coli (57 %) and Klebsiella pneumoniae (15.5 %). Thirty seven per cent of the E. coli strains were resistant to amoxicillin. Resistance rates to third generation cephalosporin were low for E. coli and other Enterobacteriaceae (3.1 and 12.2 % respectively) and mostly due to the presence of an Extended Spectrum Beta-lactamase. Resistance to cotrimoxazole and ciprofloxacin was moderate (17.8 and 15.6 % respectively). However, the resistance rate of E. coli to ciprofloxacin has significantly increased during the last 10 years. Risk factors were consistent with previously reported data, especially for the increasing ciprofloxacin resistance with age.

conclusionGeneral practitioners in Guadeloupe need to be better informed to favor the prescription of fosfomycin-trometamol to reduce the risk of resistance to fluoroquinolones.

Indexed as

Drug Resistance, BacterialAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsChildChild, PreschoolCommunity-Acquired InfectionsEnterobacteriaceaeEnterobacteriaceae InfectionsFemaleGuadeloupeHumansInfantMaleAnti-Bacterial AgentsAntibiotic resistanceEnterobacteriaceaeUrinary tract infections

Identifiers

PMID27342199
PMCPMC4919840
OpenAlexW2461495609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.